Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Scott Schoenhaus
KEY
Scott Schoenhaus
KeyBanc
Wall Street Analyst
★★★☆☆
#1094
on 13Foresight · ranked by our own returns
59%
Success Rate
+3.8%
Average Return
16 of 27 calls profitable · -7.0% vs benchmark
📈 Across the calls we could measure, roughly 59% of Scott Schoenhaus's ratings turned a profit when each position was held for 1 year — averaging +3.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

41 Buy 12 Hold 0 Sell
Scott's Stock Coverage 25 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
HNGE
Hinge Health, Inc. Class A
 Jun 12, 2026 BUY Strong Buy
+7.2% avg upside
17 analysts
$90.00
29.63% Upside
 +2.6%
ODD
ODDITY Tech Ltd. Class A
 Jun 02, 2026 HOLD Sell
+26.5% avg upside
12 analysts
 — +32.8%
HQY
Healthequity
 May 26, 2026 BUY Strong Buy
+33.5% avg upside
20 analysts
$125.00
46.62% Upside
 -1.8%
DOCS
Doximity
 May 14, 2026 HOLD Buy
+61.4% avg upside
27 analysts
 — +14.8%
ZTS
Zoetis
 May 08, 2026 HOLD Buy
+71.4% avg upside
22 analysts
 — -6.7%
OMCL
Omnicell
 Apr 29, 2026 BUY Strong Buy
+35.7% avg upside
12 analysts
$70.00
79.24% Upside
 +0.1%
PHR
Phreesia
 Apr 13, 2026 BUY Strong Buy
+82.1% avg upside
21 analysts
$12.00
27.96% Upside
 +2.5%
CERT
Certara
 Apr 13, 2026 BUY Buy
+133.5% avg upside
21 analysts
$8.00
44.43% Upside
 +4.5%
SDGR
Schrodinger
 Apr 13, 2026 BUY Strong Buy
+79.8% avg upside
14 analysts
$20.00
26.98% Upside
 +26.2%
LFMD
LifeMD
 Mar 11, 2026 BUY Strong Buy
+146.3% avg upside
13 analysts
 — +6.7%
TALK
Talkspace
 Mar 10, 2026 HOLD Buy
-13.1% avg upside
12 analysts
 — +0.2%
PGNY
Progyny
 Mar 02, 2026 BUY Strong Buy
+11.9% avg upside
14 analysts
$28.00
7.40% Upside
 +47.3%
TDOC
Teladoc
 Feb 27, 2026 HOLD Buy
+257.6% avg upside
37 analysts
 — +34.8%
ELAN
Elanco Animal Health
 Feb 25, 2026 BUY Strong Buy
+24.1% avg upside
18 analysts
$29.00
19.69% Upside
 -9.7%
ALIT
Alight
 Feb 19, 2026 HOLD Buy
+1067.0% avg upside
10 analysts
 — -18.3%
GDRX
GoodRx Holdings
 Jan 08, 2026 HOLD Buy
+387.3% avg upside
28 analysts
 — -6.5%
HCAT
Health Catalyst
 Jan 08, 2026 HOLD Buy
+216.1% avg upside
15 analysts
 — -51.4%
VEEV
Veeva Systems
 Dec 12, 2025 HOLD Strong Buy
+54.2% avg upside
36 analysts
 — -22.3%
SLP
Simulations Plus
 Oct 29, 2025 HOLD Buy
+90.1% avg upside
11 analysts
 — -8.3%
ABSI
AbSci
 Apr 16, 2025 BUY Strong Buy
+36.3% avg upside
18 analysts
$9.00
21.50% Upside
 +5.9%
ABCL
AbCellera Biologics
 Apr 16, 2025 BUY Strong Buy
+137.9% avg upside
15 analysts
$5.00
9.62% Downside
 +60.2%
LFST
Lifestance Health Group
 Apr 08, 2025 BUY Strong Buy
+8.4% avg upside
14 analysts
$9.00
0.32% Upside
 +0.1%
RXRX
Recursion Pharmaceuticals
 Jan 08, 2025 BUY Buy
+146.1% avg upside
12 analysts
$10.00
209.56% Upside
 -35.3%
MDRX
Veradigm
 Sep 15, 2022 HOLD Buy
+207.0% avg upside
22 analysts
 — -26.8%
IQV
IQVIA Holdings
 Apr 16, 2021 BUY Strong Buy
+34.5% avg upside
38 analysts
$250.00
48.98% Upside
 +10.6%
🔒 20 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Scott Schoenhaus — Frequently Asked Questions
How accurate are Scott Schoenhaus's stock ratings?
Based on the calls 13Foresight could measure, about 59% of Scott's ratings were profitable over a one-year hold, with an average return of +3.8% per rating, or -7.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Scott ranked on 13Foresight?
Scott Schoenhaus is currently ranked #1094 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Scott cover?
Scott most recently has ratings on HNGE, ODD, HQY, DOCS, ZTS, OMCL, PHR, CERT, SDGR, LFMD, TALK, PGNY and 13 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.